$33.05
+0.50 (+1.54%)
Open$32.55
Previous Close$32.55
Day High$33.84
Day Low$32.15
52W High$44.60
52W Low$13.50
Volume—
Avg Volume548.8K
Market Cap2.03B
P/E Ratio—
EPS$-8.97
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
-10.7% upside
Current
$33.05
$33.05
Target
$29.51
$29.51
$22.12
$29.51 avg
$35.27
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 13.64M | 140.52M | 130.81M |
| Net Income | -515,145,397 | -116,113 | -126,311 |
| Profit Margin | -3,777.4% | -0.1% | -0.1% |
| EBITDA | -522,325,272 | -178,287 | -168,053 |
| Free Cash Flow | — | -139,366 | -118,293 |
| Rev Growth | — | -3.7% | +16.0% |
| Debt/Equity | 0.32 | 0.89 | 0.92 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |